Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen alone can lower testosterone in some transfeminine people.

Ethosomal carriers improve drug delivery through the skin better than traditional methods.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

New drug delivery systems improve treatment effectiveness and patient experience.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Optimized film improves finasteride skin absorption and treatment efficiency.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Testosterone is crucial for development, growth, and various body functions in mammals.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.